Oliver Luxxe Assets LLC Horizon Therapeutics Public LTD CO Transaction History

Oliver Luxxe Assets LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $70,983 - $104,025	894 Added 5.57%	16,949 $1.35 Million
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $47,271 - $60,066	547 Added 3.53%	16,055 $1.69 Million
Q4 2021 Feb 16, 2022	BUY	$98.56 - $119.91 $169,030 - $205,645	1,715 Added 12.43%	15,508 $1.67 Million
Q3 2021 Nov 10, 2021	BUY	$91.91 - $110.37 $1.27 Million - $1.52 Million	13,793 New	13,793 $1.51 Million
Q2 2021 Jul 29, 2021	SELL	$86.24 - $95.92 $1.67 Million - $1.85 Million	-19,331 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$71.83 - $95.48 $48,700 - $64,735	678 Added 3.63%	19,331 $1.78 Million
Q4 2020 Feb 04, 2021	SELL	$67.0 - $84.39 $230,748 - $290,639	-3,444 Reduced 15.59%	18,653 $1.47 Million
Q3 2020 Oct 20, 2020	SELL	$55.23 - $79.93 $47,497 - $68,739	-860 Reduced 3.75%	22,097 $1.72 Million
Q2 2020 Aug 12, 2020	BUY	$30.2 - $56.98 $693,301 - $1.31 Million	22,957 New	22,957 $1.28 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Oliver Luxxe Assets LLC, based on Form 13F filings with the SEC.

Stay updated on Oliver Luxxe Assets LLC with notifications on news.